You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
11 February 2008Synthesis, characterization and two-photon PDT efficacy studies of
triads incorporating tumor targeting and imaging components
Over the past three years we have described the rationale for using new photosensitizers (PS) with greatly enhanced
multi-photon absorption. In particular, we have synthesized new porphyrin-based photosensitizers that also incorporate
small molecule targeting agents that direct the ensemble to over-expressed tumor receptor sites, as well as Near-infrared
imaging agents that will allow practical image-guided two-photon PDT in the tissue transparency window (750-1000
nm) at laser fluences that are harmless to surrounding healthy tissue. We have previously shown (PW2006) successful
treatment of human breast cancer models (MDA-MB-231) in SCID mice, and have recently extended these studies to the
treatment of both human small cell (SC) (NCI-H69) and non-small cell (NSC) (A-459) models in SCID mice. We have
demonstrated that lung cancer xenografts can be successfully treated by irradiating from the side of the mouse opposite
the implanted tumor, thereby passing through ca. 2 cm of mouse skin, tissue and organs before encountering the bulk
tumor. These results suggest that this technology can be used to treat deep subcutaneous spontaneous tumors in larger
animal models (e.g. canine). We would also emphasize that the synthetic route to these triads attaches the targeting
moiety in the last step of the synthesis, and can be easily changed, thus allowing a myriad of targeting agents to be
employed, opening the door to the possibility of patient-specific PDT.
C. W. Spangler,J. Starkey,A. Rebane,M. Drobizhev,F. Meng, andA. Gong
"Synthesis, characterization and two-photon PDT efficacy studies of
triads incorporating tumor targeting and imaging components", Proc. SPIE 6845, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVII, 68450S (11 February 2008); https://doi.org/10.1117/12.763472
The alert did not successfully save. Please try again later.
C. W. Spangler, J. Starkey, A. Rebane, M. Drobizhev, F. Meng, A. Gong, "Synthesis, characterization and two-photon PDT efficacy studies of triads incorporating tumor targeting and imaging components," Proc. SPIE 6845, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVII, 68450S (11 February 2008); https://doi.org/10.1117/12.763472